Effects of Minocycline on Neurological Outcomes In Patients With Acute Traumatic Brain Injury: A Pilot Study.

Acute traumatic brain injury Glasgow Outcome Scale-Extended (GOS-E) Glasgow coma scale (GCS) Minocycline Neuron-specific enolase (NSE) S100B

Journal

Iranian journal of pharmaceutical research : IJPR
ISSN: 1735-0328
Titre abrégé: Iran J Pharm Res
Pays: Netherlands
ID NLM: 101208407

Informations de publication

Date de publication:
2019
Historique:
entrez: 19 9 2019
pubmed: 19 9 2019
medline: 19 9 2019
Statut: ppublish

Résumé

Traumatic brain injury (TBI) is a public health problem worldwide. Secondary damage of brain injury begins within a few minutes after the trauma and can last a long time. It can be reversible, unlike primary injury. Therefore, therapeutic intervention can be used. The aims of this study were to assess the effects of minocycline on neurological function and serum S100B protein and neuron-specific enolase (NSE) levels in patients with moderate to severe TBI. Patients with acute onset of TBI and surgical evacuation of hematoma were randomized to receive either minocycline 100 mg orally twice daily or placebo for 7 days. The primary outcomes included changes in level of S100B and NSE at different time points during the trial. Additionally, changes in Glasgow coma scale (GCS) score were evaluated. The Glasgow Outcome Scale-Extended (GOS-E) score at 6 months after injury was assessed in discharge patients. Thirty four patients were randomized into the placebo (n = 20) and treatment (n = 14) groups. There was a marginal statistically significant differences in the normalized value of S100B between groups (

Identifiants

pubmed: 31531090
doi: 10.22037/ijpr.2019.1100677
pmc: PMC6706715
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1086-1096

Références

Neurosurgery. 2001 Jun;48(6):1393-9; discussion 1399-401
pubmed: 11383749
J Neurosci. 2002 Mar 1;22(5):1763-71
pubmed: 11880505
Nature. 2002 May 2;417(6884):74-8
pubmed: 11986668
Brain. 2002 Jun;125(Pt 6):1297-308
pubmed: 12023318
Clin Exp Optom. 2000 Sep-Oct;83(5):271-273
pubmed: 12472430
Curr Opin Pharmacol. 2003 Feb;3(1):27-32
pubmed: 12550738
Restor Neurol Neurosci. 1999;14(2-3):109-114
pubmed: 12671254
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10483-7
pubmed: 12930891
J Neurosci. 2004 Mar 3;24(9):2182-90
pubmed: 14999069
BMC Neurol. 2004 Apr 26;4:7
pubmed: 15109399
Brain Inj. 2005 Oct;19(11):863-80
pubmed: 16296570
Neurosurgery. 2005 Dec;57(6):1173-82; discussion 1173-82
pubmed: 16331165
Intensive Care Med. 2007 Feb;33(2):255-60
pubmed: 17143637
Neuropsychopharmacology. 2007 Nov;32(11):2393-404
pubmed: 17406652
Exp Neurol. 2007 Oct;207(2):227-37
pubmed: 17698063
Neurology. 2007 Oct 2;69(14):1404-10
pubmed: 17909152
Lancet Neurol. 2007 Dec;6(12):1045-53
pubmed: 17980667
NeuroRehabilitation. 2007;22(5):341-53
pubmed: 18162698
Behav Brain Res. 2009 Jan 23;196(2):168-79
pubmed: 18977395
Neurol Res. 2009 Mar;31(2):183-8
pubmed: 19061541
Brain Res. 2009 Sep 29;1291:122-32
pubmed: 19631631
Acta Neurochir (Wien). 2010 Jan;152(1):1-17
pubmed: 19652904
J Neurotrauma. 2010 May;27(5):911-21
pubmed: 20166806
Arch Neurol. 2010 Dec;67(12):1442-8
pubmed: 20697034
Stroke. 2010 Oct;41(10):2283-7
pubmed: 20705929
Acta Neurochir Suppl. 2011;110(Pt 1):71-4
pubmed: 21116918
Clin Neurosurg. 2010;57:134-40
pubmed: 21280506
Neurosurgery. 2011 Jun;68(6):1624-30; discussion 1630-1
pubmed: 21368691
J Neurotrauma. 2011 Oct;28(10):2135-43
pubmed: 21770756
Neurology. 2011 Sep 20;77(12):1135-42
pubmed: 21900636
Neurol India. 2012 Jan-Feb;60(1):23-8
pubmed: 22406775
Brain. 2012 Apr;135(Pt 4):1224-36
pubmed: 22505632
Front Neurol. 2012 Jul 16;3:111
pubmed: 22811676
Neurology. 2013 Jan 8;80(2):196-202
pubmed: 23269596
J Neurotrauma. 2014 Jan 15;31(2):135-58
pubmed: 23968241
Mol Neurobiol. 2015;51(3):966-79
pubmed: 24865512
Crit Care Med. 2014 Aug;42(8):1965-6
pubmed: 25029146
J Neurosci Rural Pract. 2015 Jan;6(1):27-32
pubmed: 25552848
JAMA Neurol. 2015 Mar;72(3):355-62
pubmed: 25599342
Neuropsychiatr Dis Treat. 2015 Jan 08;11:97-106
pubmed: 25657582
J Head Trauma Rehabil. 2017 May/Jun;32(3):E57-E64
pubmed: 27323216
Cell Mol Neurobiol. 2017 May;37(4):571-585
pubmed: 27383839
J Neuroinflammation. 2016 Oct 11;13(1):264
pubmed: 27724914
Acta Neurochir (Wien). 2017 Feb;159(2):209-225
pubmed: 27957604
J Head Trauma Rehabil. 2018 Jan/Feb;33(1):E44-E52
pubmed: 28520671
J Neurointerv Surg. 2017 Dec;9(12):1202-1207
pubmed: 28710084
J Neurosci Res. 2018 Apr;96(4):589-600
pubmed: 28836292
Eur J Neurol. 2017 Nov;24(11):1384-1391
pubmed: 28929560
Brain. 2018 Feb 1;141(2):459-471
pubmed: 29272357
J Forensic Leg Med. 2018 Apr;55:65-73
pubmed: 29471249
Stroke. 2018 Apr;49(4):995-1002
pubmed: 29511126
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
J Trauma. 1974 Mar;14(3):187-96
pubmed: 4814394
J Neurotrauma. 1998 Aug;15(8):587-97
pubmed: 9726258

Auteurs

Neda Koulaeinejad (N)

Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Kaveh Haddadi (K)

Department of Neurosurgery, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Saeid Ehteshami (S)

Department of Neurosurgery, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Misagh Shafizad (M)

Department of Neurosurgery, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Ebrahim Salehifar (E)

Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Omid Emadian (O)

Department of Pathology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Reza Ali Mohammadpour (R)

Department of Biostatistics, Faculty of Health Sciences, Mazandaran University of Medical Sciences, Sari, Iran.

Shahram Ala (S)

Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Classifications MeSH